Home › Funds › D. E. Shaw & Co › GENB
D. E. Shaw & Co position in GENB
GENERATE BIOMEDICINES INC · Health Care
Latest position (Q1 2026)95.00K sh
Reported value held$1.19M
Portfolio Weight0.00%
First reportedQ1 2026
Last changeNew
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 95.00K | $1.19M | New |
Other funds holding GENB
- Fidelity Management & Research (FMR) 5.22M sh · $88.09M · Q2 2026
- Capital World Investors 4.22M sh · $71.12M · Q2 2026
- Norges Bank Investment Management 2.09M sh · $35.34M · Q2 2026
- BlackRock Inc 1.66M sh · $28.00M · Q2 2026
- JPMorgan Chase & Co 1.41M sh · $23.84M · Q2 2026
- ARK Invest 1.28M sh · $21.67M · Q2 2026
- Harvard Management Company 1.11M sh · $18.74M · Q2 2026
- Geode Capital Management 735.00K sh · $12.40M · Q2 2026
- Morgan Stanley 377.99K sh · $6.38M · Q2 2026
- UBS Group AG 326.27K sh · $5.50M · Q2 2026
- Charles Schwab Investment Management 224.60K sh · $3.79M · Q2 2026
- Northern Trust Corp 197.54K sh · $3.33M · Q2 2026